AllSight
Companies · CBLL · Electromedical & Electrotherapeutic Apparatus

Ceribell, Inc. (CBLL)

Ceribell, Inc. (CBLL) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Ceribell, Inc. (CBLL) stock — financials & valuation

Key numbers for Ceribell, Inc. (CBLL): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 44/100 — a percentile rank of Ceribell, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.

Market cap$906.1M
P / S8.9×
EV / EBITDA-13.0×
Gross margin88.9%
Operating margin-68.6%
Net margin-64.7%
Return on equity-51.4%
ROIC-60.5%
Debt / equity0.2×
Dividend yield0.0%

Independent of the events above — derived from Ceribell, Inc.’s own financial statements and shown as context, never as advice.

Aug 10, 2026
Revenue beat modestly, guidance rose, but losses widened on heavier spending
Related companies in Electromedical & Electrotherapeutic Apparatus
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact